106 related articles for article (PubMed ID: 19450091)
21. [Medication of the month. The combination of budesonide 160 micrograms/formoterol 4.5 micrograms (Symbicort TH)].
Louis R
Rev Med Liege; 2002 Nov; 57(11):741-4. PubMed ID: 12564106
[TBL] [Abstract][Full Text] [Related]
22. Treatment of persistent asthma with Symbicort (budesonide/formoterol inhalation aerosol): an inhaled corticosteroid and long-acting beta2-adrenergic agonist in one pressurized metered-dose inhaler.
Berger WE; Noonan MJ
J Asthma; 2010 May; 47(4):447-59. PubMed ID: 20528601
[TBL] [Abstract][Full Text] [Related]
23. Budesonide/formoterol pressurized metered-dose inhaler for patients with persistent asthma.
Korenblat PE; Rosenwasser LJ
Allergy Asthma Proc; 2010; 31(3):190-202. PubMed ID: 20482961
[TBL] [Abstract][Full Text] [Related]
24. Budesonide/formoterol as maintenance and reliever treatment compared to fixed dose combination strategies - a Canadian economic evaluation.
Miller E; FitzGerald JM
Can J Clin Pharmacol; 2008; 15(2):e165-76. PubMed ID: 18515918
[TBL] [Abstract][Full Text] [Related]
25. Effect of budesonide/formoterol pressurized metered-dose inhaler on exacerbations versus formoterol in chronic obstructive pulmonary disease: The 6-month, randomized RISE (Revealing the Impact of Symbicort in reducing Exacerbations in COPD) study.
Ferguson GT; Tashkin DP; Skärby T; Jorup C; Sandin K; Greenwood M; Pemberton K; Trudo F
Respir Med; 2017 Nov; 132():31-41. PubMed ID: 29229103
[TBL] [Abstract][Full Text] [Related]
26. The effect of adjustable dosing with budesonide/formoterol on health-related quality of life and asthma control compared with fixed dosing.
Buhl R; Kardos P; Richter K; Meyer-Sabellek W; Brüggenjürgen B; Willich SN; Vogelmeier C
Curr Med Res Opin; 2004 Aug; 20(8):1209-20. PubMed ID: 15324523
[TBL] [Abstract][Full Text] [Related]
27. Budesonide/formoterol vs. salmeterol/fluticasone in COPD: a systematic review and adjusted indirect comparison of pneumonia in randomised controlled trials.
Halpin DM; Gray J; Edwards SJ; Morais J; Singh D
Int J Clin Pract; 2011 Jul; 65(7):764-74. PubMed ID: 21676119
[TBL] [Abstract][Full Text] [Related]
28. Budesonide/formoterol for maintenance and relief in uncontrolled asthma vs. high-dose salmeterol/fluticasone.
Bousquet J; Boulet LP; Peters MJ; Magnussen H; Quiralte J; Martinez-Aguilar NE; Carlsheimer A
Respir Med; 2007 Dec; 101(12):2437-46. PubMed ID: 17905575
[TBL] [Abstract][Full Text] [Related]
29. The whole story: treatment outcomes with Symbicort.
Zetterström ; Buhl R; Mellem H; Andersson F
Respir Med; 2002 Feb; 96 Suppl A():S29-35. PubMed ID: 11858563
[TBL] [Abstract][Full Text] [Related]
30. Budesonide/formoterol in the treatment of asthma.
Lee C; Corren J
Expert Rev Respir Med; 2008 Oct; 2(5):551-64. PubMed ID: 20477290
[TBL] [Abstract][Full Text] [Related]
31. [Budesonide/formoterol maintenance and reliever therapy. A new treatment approach for adult patients with asthma].
Korn S; Vogelmeier C; Buhl R
Med Klin (Munich); 2008 May; 103(5):299-310. PubMed ID: 18484216
[TBL] [Abstract][Full Text] [Related]
32. Budesonide/formoterol in a single inhaler (Symbicort) reduces healthcare costs compared with separate inhalers in the treatment of asthma over 12 months.
Rosenhall L; Borg S; Andersson F; Ericsson K
Int J Clin Pract; 2003 Oct; 57(8):662-7. PubMed ID: 14627174
[TBL] [Abstract][Full Text] [Related]
33. Combination of budesonide/formoterol more effective than fluticasone/salmeterol in preventing exacerbations in chronic obstructive pulmonary disease: the PATHOS study.
Larsson K; Janson C; Lisspers K; Jørgensen L; Stratelis G; Telg G; Ställberg B; Johansson G
J Intern Med; 2013 Jun; 273(6):584-94. PubMed ID: 23495860
[TBL] [Abstract][Full Text] [Related]
34. [A new fixed dose combination of fluticasone and formoterol in a pressurised metered-dose inhaler for the treatment of asthma].
Devillier P; Salvator H; Grassin-Delyle S; Naline E; Advenier C; Roche N
Rev Mal Respir; 2014 Oct; 31(8):700-13. PubMed ID: 25391505
[TBL] [Abstract][Full Text] [Related]
35. Efficacy and safety of budesonide and formoterol in one pressurised metered-dose inhaler in adults and adolescents with moderate to severe asthma: a randomised clinical trial.
Noonan M; Rosenwasser LJ; Martin P; O'Brien CD; O'Dowd L
Drugs; 2006; 66(17):2235-54. PubMed ID: 17137405
[TBL] [Abstract][Full Text] [Related]
36. A real-life cost-effectiveness evaluation of budesonide/formoterol maintenance and reliever therapy in asthma.
Ställberg B; Ekström T; Neij F; Olsson P; Skoogh BE; Wennergren G; Löfdahl CG;
Respir Med; 2008 Oct; 102(10):1360-70. PubMed ID: 18723335
[TBL] [Abstract][Full Text] [Related]
37. A comparison of budesonide/formoterol maintenance and reliever therapy versus conventional best practice in asthma management in Spain.
Quirce S; Barcina C; Plaza V; Calvo E; Muñoz M; Ampudia R; Capel M
J Asthma; 2011 Oct; 48(8):839-47. PubMed ID: 21942354
[TBL] [Abstract][Full Text] [Related]
38. Inhaled corticosteroids or long-acting beta-agonists alone or in fixed-dose combinations in asthma treatment: a systematic review of fluticasone/budesonide and formoterol/salmeterol.
Frois C; Wu EQ; Ray S; Colice GL
Clin Ther; 2009 Dec; 31(12):2779-803. PubMed ID: 20110019
[TBL] [Abstract][Full Text] [Related]
39. Onset of bronchodilation of budesonide/formoterol vs. salmeterol/fluticasone in single inhalers.
Palmqvist M; Arvidsson P; Beckman O; Peterson S; Lötvall J
Pulm Pharmacol Ther; 2001; 14(1):29-34. PubMed ID: 11162416
[TBL] [Abstract][Full Text] [Related]
40. Efficacy and safety of budesonide/formoterol single inhaler therapy versus a higher dose of budesonide in moderate to severe asthma.
Scicchitano R; Aalbers R; Ukena D; Manjra A; Fouquert L; Centanni S; Boulet LP; Naya IP; Hultquist C
Curr Med Res Opin; 2004 Sep; 20(9):1403-18. PubMed ID: 15383189
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]